Medication cost drivers in personal injury claims

Identify and manage the pharmacy spend factors that impact your claim profitability

Published: 3 April 2026 | Updated: 3 April 2026

Why medication costs matter to your bottom line

Pharmacy spend is frequently the second or third largest cost category in personal injury claims, yet it remains one of the least managed expense areas. As a claims manager, you understand cost control, but medication costs often feel disconnected from your typical levers of influence. This is a mistake. Understanding medication cost drivers transforms pharmacy from an uncontrollable expense into a strategic management opportunity.

The data is compelling. Claims with optimised medication regimens consistently close faster, cost less overall, and achieve better functional outcomes. Conversely, unchecked polypharmacy, inappropriate medication escalation, and medication-induced complications can extend claims by years and add hundreds of thousands in costs.

The five major medication cost drivers

Understanding what drives pharmacy spend in your claims allows you to identify risks early and intervene strategically. Here are the five cost drivers you need to monitor:

1. Polypharmacy and medication creep

Polypharmacy (use of multiple medications) is the single largest medication cost driver. It typically develops through medication layering: initial injury-related prescriptions are added to, but rarely reviewed for reduction. Over 12-24 months, a claimant initially on two medications can accumulate five, six, or even eight medications, each with associated costs and risks.

Medication creep happens because:

• Each treating provider addresses their specific complaint without seeing the full medication picture
• Medications prescribed for acute phase are not deprescribed when no longer needed
• Side effects from one medication are treated with additional medications rather than addressing the root cause
• Recovery plateaus lead to medication escalation rather than functional interventions

A claimant on eight medications versus three typically costs 40-60% more in pharmacy spend, plus additional complications and adverse effects driving medical costs elsewhere.

2. High-cost medication selection

Not all medications are created equal. Some therapeutic choices are significantly more expensive than alternatives with equivalent efficacy. Common high-cost drivers include:

3. Extended treatment duration

Many claimants remain on medications far longer than evidence supports. Antidepressants, anxiolytics, and pain medications prescribed in the acute phase often continue indefinitely despite lack of demonstrated ongoing benefit. Even 6-12 months of medication extension can add substantial costs, particularly with multiple medications.

Duration issues typically arise from:

• Lack of scheduled review or deprescribing plans
• Inertia in prescribing (continuing because it has always been prescribed)
• Fear of symptom return or claimant response to medication withdrawal
• Absence of functional goals to benchmark medication necessity

4. Medication-induced complications

Side effects from medications drive secondary medical costs and extend claim duration. Common costly medication complications include:

• Falls and fractures: Sedating medications increase fall risk, particularly in older claimants, leading to new injury treatment
• Gastrointestinal complications: NSAIDs and other medications increase GI bleed risk requiring hospitalisation
• Cognitive impairment: Medication-induced confusion or memory problems delay rehabilitation participation and extend recovery
• Addiction and withdrawal: Medications with dependence liability create new problems beyond the original injury
• Drug interactions: Medication combinations can create serious effects requiring acute intervention

Managing medication-induced complications often costs more than the original medications, making prevention a high-ROI investment.

5. Inadequate rehabilitation support

When rehabilitation is inadequate, medication use escalates as a substitute. Claimants without effective pain management through rehabilitation, physiotherapy, or exercise often request medication increases. Similarly, claimants not receiving psychological support for injury-related stress may use medications to manage symptoms that could be addressed through therapy.

Strong rehabilitation and psychological support reduce medication costs by 20-30% by addressing root causes rather than symptoms alone.

Identifying medication cost risks in your claims

Develop a simple medication cost screening process for your caseload:

Strategic medication cost management

Once you have identified medication cost risks, implement these management strategies:

Engage specialist medication review

Request independent clinical pharmacy assessment for claims with elevated medication costs, complex regimens, or slow functional progress. Pharmacy specialists can identify cost-saving opportunities that medical providers overlook, particularly:

• Medications no longer needed or lacking clear indication
• Opportunities to simplify from multiple medications to single agents
• High-cost medications where equally effective, lower-cost alternatives exist
• Medication combinations creating unnecessary costs or complications

Establish deprescribing goals

Work with treating providers to establish reduction targets. Rather than asking "Can we reduce medications?", ask "By what date should we target reducing X medication by 50%?" Specific goals drive action better than vague requests.

Implement medication governance reviews

Schedule regular medication reviews (quarterly or semi-annually) with your claimant's medical team to assess ongoing necessity and cost-effectiveness. Document these reviews and the rationale for any medication changes or continuations.

Link medication decisions to functional outcomes

Establish that medication changes occur only when they support functional improvement. "We're reducing your pain medication because your pain-free activity level has improved significantly" is stronger than "Your medication costs are too high."

Optimize prescribing efficiency

Where high-cost medications are necessary, ensure they are prescribed optimally:

• Request generic alternatives where clinically equivalent
• Use immediate-release formulations rather than extended-release unless clinically indicated
• Consider branded vs generic based on actual claimant benefit, not provider preference
• Unbundle combination medications where separate generics are available

Building the business case for medication investment

Strategic medication review costs money upfront but returns significant cost savings. As a claims manager, you need to understand the ROI:

• Average medication review cost: $500-1,500 depending on complexity
• Average monthly pharmacy savings from review: $300-800
• Break-even period: 2-6 months
• Year-one net savings: $2,000-6,000+ per claim reviewed
• Secondary benefits: Faster functional recovery, lower complication rates, improved claim closure

For claims with significant pharmacy spend, medication review is not discretionary; it is a foundational cost management strategy.

Common medication cost management mistakes

Mistake: Restricting medication access to reduce costs.

Better approach: Optimise medications through clinical review rather than restricting necessary treatment.

Mistake: Assuming all medication changes must come from the prescriber.

Better approach: Leverage specialist pharmacy teams to identify opportunities; let them refer for prescriber action.

Mistake: Treating medication costs as separate from overall claim management.

Better approach: Integrate medication review into your standard case management process for moderate and severe claims.

Your strategic advantage

Claims managers who understand medication cost drivers and actively manage pharmacy spend outperform peers on profitability and outcomes. Medication costs are not random or uncontrollable. They are the product of specific treatment decisions, many of which you influence through your case management approach.

By implementing systematic medication monitoring and engaging specialist review for high-risk claims, you reclaim control over a significant cost category and improve overall claim outcomes simultaneously.